Benlysta subcutaneous injection 200mg syringe, manufactured by GlaxoSmithKline, contains Belimumab (genetical recombination) (YJ code: 3999445G1027, 200mg 1mL 1 tube). This BLyS-specific inhibitor is approved for active systemic lupus erythematosus (SLE) and active lupus nephritis in adults.
Benlysta subcutaneous injection 200mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →